Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Potential cognition-enhancing agent described by Rotta

Feb. 12, 1997

Servier describes 5-HT3 agonist with additionial antagonist-like properties

Feb. 12, 1997

Cephalon and Chiron seek FDA approval for rhIGF-1

Feb. 12, 1997

Neurotrophic rotamase inhibitors described by Guilford

Feb. 12, 1997

Anticonvulsants with favorable protection indices reported by Canadian researchers

Feb. 12, 1997

Positive phase III trials results for citicoline

Feb. 11, 1997

Essential fatty acids in schizophrenia

Feb. 11, 1997

U.S. researchers report significant advance in gene therapy for hearing disorders

Feb. 11, 1997

Takeda prepares NO production inhibitors

Feb. 11, 1997

U.S. and European investigators describe agents for CNS disorders

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026